The prognostic significance of single hormone receptor positive metastatic breast cancer: An analysis of three randomised phase III trials of aromatase inhibitors
To access this article, please choose from the options below
PII: S0960-9776(10)00015-9
doi:10.1016/j.breast.2010.01.013
© 2010 Published by Elsevier Inc.
